| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 29.062 | 29.196 | 30.588 | 40.486 | 59.873 | 60.016 | 65.048 | 12.685 | - | 1.255 |
| Total Income - EUR | 29.063 | 29.197 | 30.588 | 40.487 | 59.875 | 61.067 | 65.049 | 12.685 | - | 1.348 |
| Total Expenses - EUR | 16.290 | 15.332 | 13.858 | 17.945 | 24.640 | 22.580 | 27.881 | 14.851 | - | 10.070 |
| Gross Profit/Loss - EUR | 12.773 | 13.865 | 16.730 | 22.541 | 35.234 | 38.487 | 37.168 | -2.166 | - | -8.722 |
| Net Profit/Loss - EUR | 11.901 | 13.573 | 16.424 | 22.134 | 34.635 | 37.881 | 36.517 | -2.333 | - | -8.722 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | - | 0 |
Check the financial reports for the company - Kadyaterapy Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 9.483 | 14.657 | 37.425 | 29.134 | - | 12.212 |
| Current Assets | 14.060 | 2.887 | 17.344 | 23.183 | 27.467 | 26.248 | 27.029 | 3.983 | - | 1.348 |
| Inventories | 292 | 110 | 0 | 0 | 400 | 885 | 0 | 0 | - | 0 |
| Receivables | 2.945 | 2.519 | 12.250 | 18.185 | 7.633 | 13.557 | 20.127 | 186 | - | 0 |
| Cash | 10.823 | 257 | 5.094 | 4.998 | 19.433 | 11.806 | 6.901 | 3.796 | - | 1.348 |
| Shareholders Funds | 11.955 | 2.450 | 16.477 | 22.186 | 34.686 | 37.930 | 37.219 | -1.499 | - | -19.046 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | - | 40 |
| Debts | 2.105 | 437 | 868 | 997 | 2.264 | 2.975 | 27.235 | 34.615 | - | 32.957 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Kadyaterapy Srl